Deborah J. Rew

615 total citations
10 papers, 516 citations indexed

About

Deborah J. Rew is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Deborah J. Rew has authored 10 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Pharmacology and 4 papers in Computational Theory and Mathematics. Recurrent topics in Deborah J. Rew's work include Plant biochemistry and biosynthesis (9 papers), Microbial Natural Products and Biosynthesis (4 papers) and Computational Drug Discovery Methods (4 papers). Deborah J. Rew is often cited by papers focused on Plant biochemistry and biosynthesis (9 papers), Microbial Natural Products and Biosynthesis (4 papers) and Computational Drug Discovery Methods (4 papers). Deborah J. Rew collaborates with scholars based in United States. Deborah J. Rew's co-authors include James D. Bergstrom, Marc M. Kurtz, C. DUFRESNE, J D Karkas, Vinay S. Bansal, Otto D. Hensens, Frank VanMiddlesworth, R. Bostedor, Fernando Peláez and Claude Dufresne and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Deborah J. Rew

10 papers receiving 487 citations

Peers

Deborah J. Rew
Julie L. Hutson United Kingdom
R. Bostedor United States
Iain R. Challis United Kingdom
Armin Kern Germany
Colin J. Theobald United Kingdom
Leeyuan Huang United States
Julie L. Hutson United Kingdom
Deborah J. Rew
Citations per year, relative to Deborah J. Rew Deborah J. Rew (= 1×) peers Julie L. Hutson

Countries citing papers authored by Deborah J. Rew

Since Specialization
Citations

This map shows the geographic impact of Deborah J. Rew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah J. Rew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah J. Rew more than expected).

Fields of papers citing papers by Deborah J. Rew

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah J. Rew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah J. Rew. The network helps show where Deborah J. Rew may publish in the future.

Co-authorship network of co-authors of Deborah J. Rew

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah J. Rew. A scholar is included among the top collaborators of Deborah J. Rew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah J. Rew. Deborah J. Rew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Bergstrom, James D., Richard G. Bostedor, Deborah J. Rew, et al.. (1998). Hepatic responses to inhibition of 3-hydroxy-3-methylglutaryl-CoA reductase: a comparison of atorvastatin and simvastatin. Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism. 1389(3). 213–221. 43 indexed citations
2.
Lingham, Russell B., Keith C. Silverman, Hiranthi Jayasuriya, et al.. (1998). Clavaric Acid and Steroidal Analogues as Ras- and FPP-Directed Inhibitors of Human Farnesyl-Protein Transferase. Journal of Medicinal Chemistry. 41(23). 4492–4501. 24 indexed citations
3.
Onishi, Janet C., James A. Milligan, Ángela Basilio, et al.. (1997). Antimicrobial Activity of Viridiofungins.. The Journal of Antibiotics. 50(4). 334–338. 32 indexed citations
4.
Bergstrom, James D., et al.. (1997). 2.P.24 Responses to the inhibition of HMG-CoA reductase: A comparison of simvastatin and atorvastatin. Atherosclerosis. 134(1-2). 121–121. 1 indexed citations
5.
Harris, Guy H., Claude Dufresne, H Joshua, et al.. (1995). Isolation, structure determination and squalene synthase activity of L-731,120 and L-731,128, alkyl citrate analogs of zaragozic acids A and B. Bioorganic & Medicinal Chemistry Letters. 5(20). 2403–2408. 15 indexed citations
6.
Kuo, C. H., Albert J. Robichaud, Deborah J. Rew, James D. Bergstrom, & Gregory D. Berger. (1994). Design and synthesis of squalene synthase inhibitors - acylic mimics of the zaragazic acids. Bioorganic & Medicinal Chemistry Letters. 4(13). 1591–1594. 7 indexed citations
7.
Biftu, Tesfaye, George A. Doss, Robert W. Marquis, et al.. (1993). Diesters of zaragozic acid A: Synthesis and biological activity. Bioorganic & Medicinal Chemistry Letters. 3(10). 2029–2034. 11 indexed citations
8.
Bergstrom, James D., Marc M. Kurtz, Deborah J. Rew, et al.. (1993). Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.. Proceedings of the National Academy of Sciences. 90(1). 80–84. 285 indexed citations
9.
Dufresne, Claude, Sheo B. Singh, Deborah L. Zink, et al.. (1993). Zaragozic Acids D and D2: Potent Inhibitors of Squalene Synthase and of Ras Farnesyl-Protein Transferase. Journal of Natural Products. 56(11). 1923–1929. 48 indexed citations
10.
Dufresne, Claude, Kenneth E. Wilson, Deborah L. Zink, et al.. (1992). The isolation and structure elucidation of zaragozic acid C, a novel potent squalene synthase inhibitor.. Tetrahedron. 48(47). 10221–10226. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026